CAS RN: 1202757-89-8

AVL-292

Product Availability

Choose a grade to view its available package options.

11 package records9 with current stock3 grade groups
Batch No.PackageAvailabilityWarehouseInquiry
Batchno.20250626 100mg In stock Shanghai, Wuhan, Chengdu Inquiry
Batchno.20260109 1g Out of stock Inquiry
Batchno.20260210 1mg In stock Shanghai Inquiry
Batchno.20260210 250mg In stock Shanghai Inquiry
Batchno.20250824 50mg In stock Shanghai Inquiry
Batchno.20251025 5mg In stock Shanghai Inquiry
Batch No.PackageAvailabilityWarehouseInquiry
Batchno.20250608 1ml In stock Inquiry
Batch No.PackageAvailabilityWarehouseInquiry
Batchno.20260204 100mg Out of stock Inquiry
Batchno.20250213 10mg In stock Inquiry
Batchno.20250803 50mg In stock Inquiry
Batchno.20251024 5mg In stock Inquiry
  • Product code: starshine_CAS1202757-89-8
  • Purity/Analytical Methods: >99.0%
GET A QUOTE

1202757-89-8 / N-[3-[[5-fluoro-2-[4-(2-methoxyethoxy)anilino]pyrimidin-4-yl]amino]phenyl]prop-2-enamide

spebrutinib | AVL-292 | cc-292

Standard CAS: 1202757-89-8 Multi CAS: Yes

Basic Information

CAS
1202757-89-8
Multi CAS
Yes
Molecular Formula
C22H22FN5O3
Molecular Weight
423.400000
Exact Mass
423.170668
SMILES
COCCOC1=CC=C(C=C1)NC2=NC=C(C(=N2)NC3=CC(=CC=C3)NC(=O)C=C)F
InChI
InChI=1S/C22H22FN5O3/c1-3-20(29)25-16-5-4-6-17(13-16)26-21-19(23)14-24-22(28-21)27-15-7-9-18(10-8-15)31-12-11-30-2/h3-10,13-14H,1,11-12H2,2H3,(H,25,29)(H2,24,26,27,28)
InChIKey
KXBDTLQSDKGAEB-UHFFFAOYSA-N
Synonyms
spebrutinib AVL-292 cc-292 Btk inhibitor CC-292 N-[3-[[5-fluoro-2-[4-(2-methoxyethoxy)anilino]pyrimidin-4-yl]amino]phenyl]prop-2-enamide

Computed Properties

Structural Parameters

Heavy atom count
31
Aromatic heavy atom count
18
Fraction Csp3
0.14
Rotatable bonds
10
H-bond acceptors
7
H-bond donors
3
Molar refractivity
117.64
TPSA
97.4

LogP / Solubility

WLOGP
4.25
MLOGP
3.77
XLogP3
3.6
Consensus LogP
3.87
Log S (ESOL)
-4.91
Class (ESOL)
Slightly soluble
Log S (Ali)
-6.1
Class (Ali)
Insoluble
Log S (SILICOS-IT)
-7.14
Class (SILICOS-IT)
Insoluble

ADME

GI absorption
High
BBB permeant
No
P-gp substrate
No
CYP1A2 inhibitor
Yes
CYP2C19 inhibitor
Yes
CYP2C9 inhibitor
No
CYP2D6 inhibitor
Yes
CYP3A4 inhibitor
Yes
Log Kp (skin permeation)
-2.28

Drug-likeness / Medicinal Chemistry

Lipinski
Yes
Ghose
Yes
Veber
Yes
Egan
Yes
Muegge
Yes
Bioavailability score
0.55
Brenk alerts
1
Leadlikeness
No
Synthetic Accessibility
2.5

Get In Touch

Contact Us